Legendary 'anime' Galaxy Express 999 mural put up at station

Legendary 'anime' Galaxy Express 999 mural put up at station

TOKYO, Japan - A 12.7-meter-wide, 2.8-meter-high mural of the legendary ''anime'' film ''Galaxy Express 999'' is put up at Oizumi Gakuen Station of Seibu Railway Co. in Tokyo's Nerima Ward, dubbed the birthplace of Japanese animated films.

  • Product Code
  • ILEA001132687
  • Registered date
  • 2009/3/18 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2009 Kyodo News
  • Media size
  • 1772 × 1303 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 548.03(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Maglev train tunnel

    Maglev train tunnel

    A 710-meter tunnel is completed in Fujikawa, Yamanashi Prefecture, on Oct. 13, 2023, for Central Japan Railway Co.'s Linear Chuo Shinkansen maglev trains that will run between Nagoya and Tokyo at speeds of about 500 kilometers per hour.

      Maglev train tunnel

      FUJIKAWA, Japan, Oct. 13 Kyodo - A ceremony is held in Fujikawa, Yamanashi Prefecture, on Oct. 13, 2023, to mark the completion of a 710-meter tunnel for Central Japan Railway Co.'s Linear Chuo Shinkansen maglev trains that will run between Nagoya and Tokyo at speeds of 500 kilometers per hour. (Kyodo)
        Maglev train tunnel

        Maglev train tunnel

        A ceremony is held in Fujikawa, Yamanashi Prefecture, on Oct. 13, 2023, to mark the completion of a 710-meter tunnel for Central Japan Railway Co.'s Linear Chuo Shinkansen maglev trains that will run between Nagoya and Tokyo at speeds of 500 kilometers per hour.
          Maglev train tunnel

          Maglev train tunnel

          A 710-meter tunnel is completed in Fujikawa, Yamanashi Prefecture, on Oct. 13, 2023, for Central Japan Railway Co.'s Linear Chuo Shinkansen maglev trains that will run between Nagoya and Tokyo at speeds of about 500 kilometers per hour.

            Seibu Ikebukuro workers strike

            TOKYO, Japan - Striking workers represented by a labor union at Japanese department store operator Sogo & Seibu Co. march in the streets of Tokyo's Toshima Ward on Aug. 31, 2023. Store workers are opposing plans by parent Seven & i Holdings Co. to sell the 10-store chain to a U.S.-based investment fund.
              Seibu Ikebukuro workers strike

              Seibu Ikebukuro workers strike

              Striking workers represented by a labor union at Japanese department store operator Sogo & Seibu Co. march in the streets of Tokyo's Toshima Ward on Aug. 31, 2023. Store workers are opposing plans by parent Seven & i Holdings Co. to sell the 10-store chain to a U.S.-based investment fund.
                Food delivery robot

                Food delivery robot

                A food delivery robot enters an elevator to deliver lunch, snacks and other food in an office building in Tokyo during a media demonstration on Jan. 10, 2023, held a day ahead of a 17-day test operation by East Japan Railway Co. and KDDI Corp.
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.